Interactive Brokers Stock Rallies After Q2 Earnings Report: Here's Why

Zinger Key Points

Interactive Brokers Group, Inc. IBKR released its second-quarter results after Thursday's closing bell. Here's a look at the key figures from the quarter. 

The Details: Interactive Brokers reported quarterly earnings of 51 cents per share, which beat the analyst consensus estimate of 45 cents. Quarterly revenue of $1.48 billion beat the Street estimate of $1.36 billion and is an increase over revenue of $1.23 billion from the same period last year.

Read Next: Rare Earth Royalty: Meet The Power Players Shaping The Industry

For the second quarter, Interactive Brokers reported:

  • Commission revenue increased 27% to 516 million on higher customer trading volumes.
  • Customer trading volume in stocks, options and futures increased 31%, 24% and 18%, respectively.
  • Net interest income increased 9% to $860 million on higher average customer credit balances and securities lending activity.
  • Customer accounts increased 32% to 3.87 million.
  • Customer equity increased 34% to $664.6 billion.
  • Total DARTs increased 49% to 3.55 million.
  • Customer credits increased 34% to $143.7 billion.
  • Customer margin loans increased 18% to $65.1 billion.

IBKR Price Action: According to data from Benzinga Pro, Interactive Brokers stock was up 3.15% at $61.39 in Thursday's extended trading. 

Loading...
Loading...

Read Next: 

Photo: Piotr Swat via Shutterstock

IBKR Logo
IBKRInteractive Brokers Group Inc
$61.673.74%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
93.06
Growth
93.15
Quality
89.38
Value
59.62
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

fintech-banner
Fintech Focus Newsletter
Your update on what's going on in the Fintech space. Keep up-to-date with news, valuations, mergers, funding, and events. Sign up today!
Comments
Loading...